Molecular Partners AG (LON:0QXX)
London · Delayed Price · Currency is GBP · Price in CHF 3.508
-0.055 (-1.54%)
Feb 10, 2026, 10:32 AM GMT
Molecular Partners AG Market Cap
Molecular Partners AG has a market cap or net worth of 126.19 million as of February 12, 2026. Its market cap has decreased by -18.62% in one year.
Market Cap
126.19M
Enterprise Value
27.89M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
3.51
Market Cap Chart
Since November 4, 2014, Molecular Partners AG's market cap has decreased from 277.60M to 126.19M, a decrease of -54.54%. That is a compound annual growth rate of -6.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 12, 2026 | 126.19M | 6.18% |
| Dec 30, 2025 | 118.85M | -9.87% |
| Dec 30, 2024 | 131.86M | 25.14% |
| Dec 29, 2023 | 105.37M | -41.44% |
| Dec 30, 2022 | 179.94M | -61.42% |
| Dec 30, 2021 | 466.39M | -7.36% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 219.68B |
| GSK plc | 87.00B |
| Haleon | 35.66B |
| Smith & Nephew | 10.94B |
| Diaceutics | 142.24M |
| Scancell Holdings | 128.68M |
| Shield Therapeutics | 114.81M |
| EKF Diagnostics Holdings | 107.99M |